📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition. (2019)

First Author: Brumpton BM

Attributed to: Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/circgen.118.002335

PubMed Identifier: 30645169

Publication URI: http://europepmc.org/abstract/MED/30645169

Type: Journal Article/Review

Volume: 12

Parent Publication: Circulation. Genomic and precision medicine

Issue: 1

ISSN: 2574-8300